Musclin inhibits insulin activation of Akt/protein kinase B in rat skeletal muscle

Journal of International Medical Research

Volumn 36, Issue 3, 2008, Pages 496-504

  Liu, Y ^a   Huo, X ^a   Pang, X F ^a   Zong, Z H ^a   Meng, X ^a   Liu, Guo Liang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Akt PBK; Diabetis mellitus; Insulin resistance; LXR ; Musclin; PI3K; PPAR ; Rats; Rosiglitazone; Thiazolidinedione

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; LIVER X RECEPTOR ALPHA; MESSENGER RNA; MUSCLE PROTEIN; MUSCLIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; ROSIGLITAZONE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; ENZYME INHIBITION; EXTENSOR DIGITORUM LONGUS MUSCLE; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; INSULIN RESISTANCE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

EID: 45149128600     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000803600314     Document Type: Article

References (19)

1. Nieto-Vazquez I, Fernández-Veledo S, de Alvaro C, et al: Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-α-induced insulin resistance. Diabetes 2007; 56: 404-413.
2. Fernańdez AM, Kim JK, Yakar S, et al: Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev 2001; 15: 1926-1934.
3. Zisman A, Peroni OD, Abel ED, et al: Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 2000; 8: 924-928.
4. Nishizowa. H, Matsuda M, Yamada Y, et al: Musclin, a novel skeletal muscle-derived secretory factor. J Biol Chem 2005; 279: 19391-19395.
5. Liu Y, Zong ZH, Liu GL: Musclin reduced insulin-induced differented rat myocytes glucose uptake is related to P13K/AKT (PKB) pathway. Clin J New Drugs 2007; 19: 1585-1588.
6. Ryder J, Yang J, Galuska D, et al: Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes 2000; 49: 647-654.
7. Koistinen HA, Galuska D, Chibalin AV, et al: 5-Amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes 2003; 52: 1066-1072.
8. Lizcano JM, Alessi DR: The insulin signalling pathway. Curr Biol 2002; 12: R236-R238.
9. Wong JT, Kim PT, Peacock JW, et al: Pten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity. Diabetologia 2007; 50: 395-403.
10. Kurowski TG, Lin YS, Lou ZJ, et al: Hyperglycemia inhibits insulin activation of AKT/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle. Diabetes 1999; 48: 658-663.
11. Lebovitz HE: Type 2 diabetes: an overview. Clin Chem 1999; 45: 1339-1345.
12. Bhatia V, Viswanathan P: Insulin resistance and PPAR insulin sensitizers. Curr Opin Investig Drugs 2006; 10: 891-897.
13. Chen A, Brar B, Choi CS, et al: Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle. Proc Natl Acad Sci USA 2006; 103: 16580-16585.
14. Butler M, McKay RA, Popoff IJ, et al: Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes 2002; 51: 1028-1034.
15. Farese RV, Sajan MP, Standaert ML: Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes. Exp Biol Med 2005; 230: 593-605.
16. Staiger H, Haas C, Machicao F, et al: The PPAR agonist troglitazone induces musclin mRNA expression in human myotubes. Horm Metab Res 2006; 38: 614-616.
17. Gelman L, Feige JN, Desvergne B: Molecular basis of selective PPARγ modulation for the treatment of Type 2 diabetes. Biochim Biophys Acta 2007; 1771: 1094-1107.
18. Juvet LK, Andresen SM, Schuster GU, et al: On the role of liver X receptors in lipid accumulation in adipocytes. Mol Endocrinol 2003; 17: 172-182.
19. Dalen KT, Ulven SM, Bamberg K, et al: Expression of the insulin-responsive glucose transporter GLUT4 in adipocytes is dependent on liver X receptor α. J Biol Chem 2003; 278: 48283-48291.